A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

Scientists have reported a major breakthrough in our understanding of inflammatory bowel disorder. It could lead to more effective treatments for conditions like Crohn's disease, a new study found.

Although several treatment options exist in the management of Crohn's disease, a patient-centered approach is integral amid ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

LGBTQ patients afflicted with inflammatory bowel disease, an autoimmune condition that affects some 2 million to 3 million ...

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

Opioid use is more prevalent among individuals with vs without IBD, although not related to a psychiatric comorbidity.

Tulisokibart is a tumor necrosis factor (TNF)-like cytokine 1A (TL1A) monoclonal antibody with a different mechanism of ...

Advertisement Ulcerative colitis affects over 900,000 Americans and is a form of inflammatory bowel disease (IBD). The exact ...

A three-day National Inflammatory Bowel Disease (IBD) Conference and the second roundtable meeting of the BRICS IBD Consortium, being organised by the Vizag Gut Club Association in collaboration with ...

Pseudopolyps ocurr due to the inflammation related to Crohn's disease or ulcerative colitis. Learn what pseudopolyps on ...